In November 2025, the drugmaker Novo Nordisk announced that two large and much anticipated studies failed to find any benefit for its GLP-1 medicine in patients with early stage Alzheimers disease
no cards are processed on site
Active ingredient : semaglutide Inactive ingredients: Ozempic: disodium phosphate dihydrate, propylene glycol, phenol, and water for injections
The study in a pain model shows that the formulation reduced pain, worked rapidly and did not seep through into the bloodstream
The tool evaluates five key domains such as selection, measurement validity, confounding, and data analysis
We prioritize transparency and clean sourcing in everything we create